Related Experiment Videos

Zinc as an inhibitor of myelin basic protein proteolytic breakdown in the central nervous system

G M Liuzzi1, A Ventola, T Rizzo

  • 1Dipartimento di Biochimica e Biologia Molecolare, Università di Bari, Italy.

Acta Neurologica
|April 1, 1991
PubMed

Insights

Zinc acetate inhibits the degradation of myelin basic protein (MBP) by central nervous system enzymes. This suggests a zinc-dependent metallo-protease may target MBP within the myelin sheath.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Proteomics

Background:

  • Central nervous system (CNS) myelin contains proteolytic enzymes.
  • These enzymes are known to degrade myelin basic protein (MBP).
  • Understanding these degradation processes is crucial for CNS health.

Purpose of the Study:

  • To investigate the inhibitory effect of zinc acetate on MBP degradation.
  • To characterize the nature of the MBP-degrading activity.
  • To explore the potential role of zinc in regulating MBP proteolysis in situ.

Main Methods:

  • Enzyme inhibition assays using zinc acetate.
  • Analysis of water-soluble MBP-degrading activity.
  • Testing enzyme activity on lipid-bound MBP.

Main Results:

  • Zinc acetate inhibits MBP cleavage at concentrations of 1 mM or higher.
  • The zinc-inhibitable activity is water-soluble.
  • The enzyme recognizes MBP even when protected in a lipid-bound form.

Conclusions:

  • A zinc-dependent metallo-protease likely degrades MBP in the CNS.
  • This protease may act on MBP within the myelin sheath before its release from the membrane.
  • Zinc may play a regulatory role in myelin proteolysis.

Related Concept Videos